Explore EATRIS as a companya patienta scientista policy-makera visitor Login
EMA updates procedural advice to clarify regulatory process for Advanced Therapy Medicinal Products
ID-EPTRI: a new research infrastructure for better paediatric medicines emerges
2nd open call for RItrain knowledge exchange – profit from the expertise of other Research Infrastructures
New funding opportunity for neurodegenerative disease launched by NeurATRIS
Sweden begins the year by becoming a full member
Five reasons not to miss EMA’s Awareness Sessions, this March
National PET Center in Turku signs collaboration agreement to develop imaging for tissue fibrosis research, with help from EATRIS
Funding agency in the Netherlands supporting EATRIS
Funding agency in Latvia supporting EATRIS
Funding agency in Slovenia supporting EATRIS
Funding agency in Portugal supporting EATRIS
Funding agency in Luxembourg supporting EATRIS
Funding agency in Italy supporting EATRIS
Funding agency in France supporting EATRIS
Funding agency in Finland supporting EATRIS
Funding agency in Czech Republic supporting EATRIS
Funding agency in Bulgaria supporting EATRIS
Funding agency in Spain supporting EATRIS
